Frontier Capital Management Co. LLC increased its holdings in PRA Health Sciences Inc (NASDAQ:PRAH) by 2.8% in the 1st quarter, HoldingsChannel reports. The fund owned 896,923 shares of the medical research company’s stock after purchasing an additional 24,207 shares during the period. Frontier Capital Management Co. LLC’s holdings in PRA Health Sciences were worth $98,922,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Raymond James Financial Services Advisors Inc. acquired a new position in shares of PRA Health Sciences during the 1st quarter valued at about $1,718,000. Shaker Investments LLC OH acquired a new position in shares of PRA Health Sciences during the 1st quarter valued at about $1,412,000. State Treasurer State of Michigan increased its holdings in shares of PRA Health Sciences by 1.0% during the 1st quarter. State Treasurer State of Michigan now owns 21,000 shares of the medical research company’s stock valued at $2,316,000 after acquiring an additional 200 shares during the last quarter. Lyell Wealth Management LP increased its holdings in shares of PRA Health Sciences by 41.3% during the 1st quarter. Lyell Wealth Management LP now owns 35,622 shares of the medical research company’s stock valued at $3,929,000 after acquiring an additional 10,407 shares during the last quarter. Finally, Chase Investment Counsel Corp grew its holdings in PRA Health Sciences by 4.0% in the 1st quarter. Chase Investment Counsel Corp now owns 16,457 shares of the medical research company’s stock valued at $1,815,000 after buying an additional 630 shares during the last quarter. 98.14% of the stock is owned by hedge funds and other institutional investors.

Shares of PRA Health Sciences stock traded up $1.76 during midday trading on Thursday, hitting $90.13. 8,046 shares of the company were exchanged, compared to its average volume of 515,874. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.90 and a quick ratio of 0.90. The company has a market capitalization of $5.86 billion, a PE ratio of 22.89, a price-to-earnings-growth ratio of 1.20 and a beta of 1.01. PRA Health Sciences Inc has a 52 week low of $79.20 and a 52 week high of $121.98.

PRA Health Sciences (NASDAQ:PRAH) last posted its earnings results on Wednesday, February 27th. The medical research company reported $1.21 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.18 by $0.03. The business had revenue of $729.65 million during the quarter, compared to the consensus estimate of $750.67 million. PRA Health Sciences had a return on equity of 26.87% and a net margin of 5.50%. Equities analysts anticipate that PRA Health Sciences Inc will post 4.63 earnings per share for the current fiscal year.

PRAH has been the subject of a number of research reports. Robert W. Baird raised their price objective on PRA Health Sciences from $119.00 to $122.00 and gave the stock an “outperform” rating in a research report on Thursday, February 28th. BidaskClub downgraded PRA Health Sciences from a “hold” rating to a “sell” rating in a research report on Friday, April 19th. Wolfe Research initiated coverage on PRA Health Sciences in a research report on Tuesday, April 2nd. They issued a “market perform” rating for the company. ValuEngine downgraded PRA Health Sciences from a “buy” rating to a “hold” rating in a research report on Saturday, April 13th. Finally, SunTrust Banks raised their price objective on PRA Health Sciences to $120.00 and gave the stock an “average” rating in a research report on Monday, March 4th. One analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $113.22.

TRADEMARK VIOLATION WARNING: “PRA Health Sciences Inc (PRAH) Shares Bought by Frontier Capital Management Co. LLC” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://theolympiareport.com/2019/05/16/pra-health-sciences-inc-prah-shares-bought-by-frontier-capital-management-co-llc.html.

PRA Health Sciences Profile

PRA Health Sciences, Inc, a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services.

Featured Article: Recession

Want to see what other hedge funds are holding PRAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PRA Health Sciences Inc (NASDAQ:PRAH).

Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.